Investment
Features
FeesSafety
Academy
More
Pluang+

Investigation launched into ADMA Biologics over alleged revenue inflation and channel stuffing.

Market News
26 Mar 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

Holzer & Holzer, LLC is investigating ADMA Biologics, Inc. following a report accusing the company of inflating its revenue through channel stuffing and undisclosed related party distributors. The report claims ADMA's actual revenue declined by 3% in 2025, contrary to the 20% growth reported. This allegation caused ADMA's stock price to drop, prompting potential investors who suffered losses to seek legal advice. The investigation could lead to shareholder litigation if misconduct is confirmed.

More News (ADMA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App